CoChat

The DOI matches its Crossref record; 73 of the 75 references it cites were found in a registry or an index.

Mechanisms of Hepatic Very Low-Density Lipoprotein Overproduction in Insulin Resistance

Adeli, Khosrow, Taghibiglou, Changiz, Van Iderstine, Stephen C, Lewis, Gary F · 2001 · Trends in Cardiovascular Medicine

Abstract

An important complication of insulin-resistant states, such as obesity and type 2 diabetes, is an atherogenic dyslipidemia profile characterized by hypertriglyceridemia, low plasma high-density lipoproteins (HDL) cholesterol and a small, dense low-density lipoprotein (LDL) particle profile. The physiological basis of this metabolic dyslipidemia appears to be hepatic overproduction of apoB-containing very low-density lipoprotein (VLDL) particles. This has focused attention on the mechanisms that regulate VLDL secretion in insulin-resistant states. Recent studies in animal models of insulin resistance, particularly the fructose-fed hamster, have enhanced our understanding of these mechanisms, and certain key factors have recently been identified that play important roles in hepatic insulin resistance and dysregulation of the VLDL secretory process. This review focuses on these recent developments as well as on the hypothesis that an interaction between enhanced flux of free fatty acids from peripheral tissues to liver, chronic up-regulation of de novo lipogenesis by hyperinsulinemia and attenuated insulin signaling in the liver may be critical to the VLDL overproduction state observed in insulin resistance. It should be noted that the focus of this review is on molecular mechanisms of the hypertriglyceridemic state associated with insulin resistance and not that observed in association with insulin deficiency (e.g., in streptozotocin-treated animals), which appears to have a different etiology and is related to a catabolic defect rather than secretory overproduction of triglyceride-rich lipoproteins.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1050-1738(01)00084-6

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 73 references

Research works printed but not linked: 1

  1. Chan, 2000, Apolipoprotein B, Recent Prog Horm Res, 55, 93

Cited by

See all 198

Metadata

Authors
Adeli, K., Taghibiglou, C., Van Iderstine, S. C., & Lewis, G. F.
Affiliations
University of Toronto (CA)
Corresponding author
Adeli, Khosrow
Venue
Trends in Cardiovascular Medicine
Publisher
Elsevier BV
Published
2001-07
Volume
11
Issue
5
Pages
170-176
ISSN
1050-1738 (ISSN-L)
OpenAlex
W2034751031
Cited by
194
References
75
Citations by year
2026: 2 · 2025: 5 · 2024: 3 · 2023: 5 · 2022: 4 · 2021: 3 · 2020: 4 · 2019: 4 · 2018: 7 · 2017: 9 · 2016: 9 · 2015: 6 · 2014: 9 · 2013: 10 · 2012: 5
FWCI
2.13
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Trends in Cardiovascular Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
insulin resistance, very low density lipoprotein secretion, hypertriglyceridemia, dyslipidemia, hepatic insulin resistance, de novo lipogenesis, hyperinsulinemia, type 2 diabetes, obesity
MeSH terms
Animals, Apolipoproteins B, Carrier Proteins, Fatty Acids, Nonesterified, Insulin Resistance, Lipoproteins, VLDL, Liver, Receptor, Insulin, Hypertriglyceridemia, Signal Transduction, Models, Animal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanisms of Hepatic Very Low-Density Lipoprotein Overproduction in Insulin Resistance. https://app.cochat.ai/papers/10.1016/s1050-1738(01)00084-6
The paper
Adeli, K., Taghibiglou, C., Van Iderstine, S. C., & Lewis, G. F. (2001). Mechanisms of Hepatic Very Low-Density Lipoprotein Overproduction in Insulin Resistance. Trends in Cardiovascular Medicine. https://doi.org/10.1016/s1050-1738(01)00084-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.